These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29465693)

  • 1. Scaling Up Human Immunodeficiency Virus Screening and Antiretroviral Therapy Among Men Who Have Sex With Men to Achieve the 90-90-90 Targets in China.
    Zhuang X; Peng P; Sun H; Chu M; Jiang S; Jiang L; Zhou P; Zhu B; Zhang L
    Sex Transm Dis; 2018 May; 45(5):343-349. PubMed ID: 29465693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
    Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
    BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China.
    Zhang L; Peng P; Wu Y; Ma X; Soe NN; Huang X; Wu H; Markowitz M; Meyers K
    AIDS Behav; 2019 Feb; 23(2):523-533. PubMed ID: 29971734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States.
    Zulliger R; Maulsby C; Solomon L; Baytop C; Orr A; Nasrullah M; Shouse L; DiNenno E; Holtgrave D
    AIDS Behav; 2017 Mar; 21(3):619-625. PubMed ID: 27624729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India.
    Kazemian P; Costantini S; Kumarasamy N; Paltiel AD; Mayer KH; Chandhiok N; Walensky RP; Freedberg KA
    Clin Infect Dis; 2020 Feb; 70(4):633-642. PubMed ID: 30921454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.
    Juusola JL; Brandeau ML; Long EF; Owens DK; Bendavid E
    AIDS; 2011 Sep; 25(14):1779-87. PubMed ID: 21716076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among MSM.
    Trickey A; Walker JG; Bivegete S; Semchuk N; Saliuk T; Varetska O; Stone J; Vickerman P
    AIDS; 2022 Nov; 36(14):2025-2034. PubMed ID: 36305181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
    Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
    N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
    Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM.
    Phillips AN; Cambiano V; Miners A; Lampe FC; Rodger A; Nakagawa F; Brown A; Gill ON; De Angelis D; Elford J; Hart G; Johnson AM; Lundgren JD; Collins S; Delpech V
    AIDS; 2015 Sep; 29(14):1855-62. PubMed ID: 26372391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Community-based Human Immunodeficiency Virus Self-Testing in Blantyre, Malawi.
    Maheswaran H; Clarke A; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Petrou S
    Clin Infect Dis; 2018 Apr; 66(8):1211-1221. PubMed ID: 29136117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
    Long EF; Brandeau ML; Owens DK
    Ann Intern Med; 2010 Dec; 153(12):778-89. PubMed ID: 21173412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supernatural Explanatory Models of Health and Illness and HIV Antiretroviral Therapy Use Among Young Men Who Have Sex with Men in China.
    Pan SW; Smith MK; Carpiano RM; Fu H; Ong JJ; Huang W; Tang W; Tucker JD
    Int J Behav Med; 2020 Oct; 27(5):602-608. PubMed ID: 32415590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cost-Effectiveness of Syphilis Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis.
    Chesson HW; Kidd S; Bernstein KT; Fanfair RN; Gift TL
    Sex Transm Dis; 2016 Jul; 43(7):429-32. PubMed ID: 27322043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences Between Men Who Have Sex with Men (MSM) with Low CD4 Cell Counts at Their First HIV Test and MSM with Higher CD4 Counts in Bangkok, Thailand.
    Sapsirisavat V; Phanuphak N; Sophonphan J; Egan JE; Langevattana K; Avihingsanon A; Friedman MR; Stall R;
    AIDS Behav; 2016 Dec; 20(Suppl 3):398-407. PubMed ID: 27329100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving 90-90-90 Human Immunodeficiency Virus (HIV) Targets Will Not Be Enough to Achieve the HIV Incidence Reduction Target in Australia.
    Scott N; Stoové M; Kelly SL; Wilson DP; Hellard ME
    Clin Infect Dis; 2018 Mar; 66(7):1019-1023. PubMed ID: 29099920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.